Why the study?
Arrhythmogenic cardiomyopathy is an incurable progressive disease linked to desmosomal adhesion mutations, but the underlying molecular dysfunctions are not well characterized.
Key points are not available for this paper at this time.
Population
Two murine AC models
Design
Animal experimental study
Arrhythmogenic cardiomyopathy (AC) is an incurable progressive disease that is linked to mutations in genes coding for components of desmosomal adhesions that are localized to the intercalated disc region, which electromechanically couples adjacent cardiomyocytes. To date, the underlying molecular dysfunctions are not well characterized. In two murine AC models, we find an upregulation of the skeletal muscle actin gene (Acta1) known to be a compensatory reaction to compromised heart function. It is elevated prior to visible morphological alterations and clinical symptoms and persists throughout pathogenesis with an additional major rise during the chronic disease stage. We provide evidence that the increased Acta1 transcription is initiated through nuclear activation of the serum response transcription factor (SRF) by its transcriptional co-activator megakaryoblastic leukemia 1 protein (MKL1). Our data further suggest that perturbed desmosomal adhesion causes Acta1 overexpression during early disease which is amplified by transforming growth factor beta release from fibrotic lesions and surrounding cardiomyocytes during later disease stages. These observations highlight a hitherto unknown molecular AC pathomechanism.
No takes yet. Share an insight, caveat, or question.
Kant et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: